Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Windmill Road, Oxford, OX3 7LD, UK
Medical Officer Division of Urology, Obstetrics and Gynecology, Center for Drug and Evaluation Research, US Food and Drug Administration, Silver Spring, MD
Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK
Assistant Professor Division of Biostatistics and Health Services Research, Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School
MD, PhD fellow Center of Research and Disruption of Infectious Diseases, Department of Infectious Diseases, Copenhagen University Hospital, Amager and Hvidovre, Hvidovre, Denmark
Professor Center of Research and Disruption of Infectious Diseases, Department of Infectious Diseases, Copenhagen University Hospital, Amager and Hvidovre, Hvidovre, Denmark
MSc EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance)
Department of Epidemiology & Data Science, Amsterdam UMC – Vrije Universiteit, Amsterdam Public Health, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands
Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa; Unit of Adverse Drug Reactions Monitoring, University Hospital of Pisa, Pisa, Italy
EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance
Pharmcoepidemiologist Division of Epidemiology, Office of Surveillance and epidemiology,Center for Drug Evaluation and Research, US Food and Drug Administration
Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania (Philadelphia, PA, US)
Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, United Kingdom
Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK
Department of Pharmacological and Biomolecular Sciences, Epidemiology and Preventive Pharmacology Service (SEFAP), University of Milan, via Balzaretti 9, 20133, Milan, Italy
Department of Pharmacological and Biomolecular Sciences, Epidemiology and Preventive Pharmacology Service (SEFAP), University of Milan, via Balzaretti 9, 20133, Milan, Italy
Department of Pharmacological and Biomolecular Sciences, Epidemiology and Preventive Pharmacology Service (SEFAP), University of Milan, via Balzaretti 9, 20133, Milan, Italy
Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; The University of Hong Kong Shenzhen Institute of Research and Innovation, Shenzhen, China
Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester
Full professor Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy
EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance
Department of Statistics and Quantitative Methods, Division of Biostatistics, Epidemiology and Public Health, University of Milano-Bicocca, Milan, Italy
EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], and French National Health Insurance [CNAM]), Saint-Denis, France
EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance
Department of Medical Pharmacology and Toxicology, CHU Montpellier University Hospital, Montpellier, France; Laboratory of Biostatistics, Epidemiology and Public Health (EA 2415), Faculty of Medicine, University of Montpellier, F-34295 Montpellier, France
Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Department of Research - Cancer Registry of Norway, Institute of Population-Based Cancer Research
Department of Epidemiology & Data Science, Amsterdam UMC – Vrije Universiteit, Amsterdam Public Health, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands
Centre for Occupational and Environmental Health, Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester
EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance)
Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK
Centre for Dermatology Research, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Division of Musculoskeletal and Dermatological Sciences, University of Manchester
Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital of Basel, Basel Switzerland
Associate Professor School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan
EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], and French National Health Insurance [CNAM]), Saint-Denis, France.
EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], and French National Health Insurance [CNAM]), Saint-Denis, France
Post-Doctorate Fellow, Infectious Diseases/Antimicrobial Stewardship Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI, United States
School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan
Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania (Philadelphia, PA, US)
Department of Clinical and Medical Pharmacology and Regional Pharmacovigilance Centre, Faculty of Medicine and Toulouse University Hospital, Toulouse, France
Department of Epidemiology, Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, University Hospital of Bordeaux, Clinical Pharmacology, F-33000 Bordeaux, France
PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo
Department of Pharmacological and Biomolecular Sciences, Epidemiology and Preventive Pharmacology Service (SEFAP), University of Milan, via Balzaretti 9, 20133, Milan, Italy
Division of Informatics, Imaging and Data Sciences, Manchester Academic Health Sciences Centre, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester
Professor of Pharmaco- and Device Epidemiology Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, United Kingdom
Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
Exec Med Dir Clinical Safety and Pharmacovigilance, Daiichi Sankyo Inc Basking Ridge, NJ and CCEB/CPeRT, University of Pennsylvania Perelman School of Medicine
Center of Research and Disruption of Infectious Diseases, Department of Infectious Diseases, Copenhagen University Hospital, Amager and Hvidovre, Hvidovre, Denmark
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance
Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Windmill Road, Oxford, OX3 7LD, UK
School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan
Department of Dentistry – Quality and Safety of Oral Healthcare, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands
Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK
Director of the Centre of Clinical Epidemiology Departments of Epidemiology and Biostatistics, Faculty of Medicine, McGill University, Montreal, Canada
Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, Hospital Charles Perrens, F-33000 Bordeaux, France
Department of Pharmacological and Biomolecular Sciences, Epidemiology and Preventive Pharmacology Service (SEFAP), University of Milan, via Balzaretti 9, 20133, Milan, Italy
Assistant Professor Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research (NIPER) Guwahati, Kamrup, Assam, India.
Department of Primary and Community Care, Academic Collaborative Center AMPHI, Integrated Health Policy, Radboud University Medical Center, Nijmegen, the Netherlands
Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania (Philadelphia, PA, US)
Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance)
.jpg "AMDANY, HENRY photo")
.jpg "Ball, Robert photo")
.jpg "Boutmy, Emmanuelle photo")
.jpg "Crown, William photo")
.jpg "Denig, Petra photo")
.jpg "Groenwold, Rolf photo")
.jpg "Mahrus, Sami photo")
.jpg "Robinson, Whitney photo")
.jpg "Undela, Krishna photo")
.jpg "Wang, Chi-Chuan photo")
